Staphylococcus Aureus Endocarditis: Clinical Trials

1 trial for Staphylococcus Aureus Endocarditis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Staphylococcus Aureus Endocarditis: new trials by email Literature Review of Staphylococcus Aureus Endocarditis trials Research Report on Staphylococcus Aureus Endocarditis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia
CF-301, Placebo - Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis
Phase 2CompletedContraFect1212017-05-232021-10-08

Narrower conditions

Bacteremia (1)  ·  Staphylococcal Infections (1)

Broader conditions

Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sepsis (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

exebacase (1)

Sponsors

ContraFect (1)

Countries

Belgium (1)  ·  Bulgaria (1)  ·  Chile (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Guatemala (1)  ·  Israel (1)  ·  Italy (1)  ·  Russia (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 32271718